H11.06
Recurrent pterygium of eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Recurrent pterygium of the eye is a condition characterized by the growth of a fibrovascular tissue extending from the conjunctiva onto the cornea. This growth often recurs even after treatment, leading to potential vision problems and discomfort. The condition is identified with the ICD-10 code H11.06, emphasizing its recurrent nature. Pterygiums are generally linked to environmental exposure and can impact vision if they extend over the pupillary area. Managing recurrent pterygium involves careful observation and tailored treatment strategies to prevent progression and restore ocular health.
Causes & Symptoms
Clinical Causes: Chronic exposure to ultraviolet (UV) light, especially from sunlight Prolonged exposure to wind, dust, or wind-blown particles Geographical factors, such as living in sunny or arid regions History of previous pterygium surgery, leading to recurrence Genetic predisposition in some individuals Chronic ocular surface inflammation
Key Symptoms: A fleshy, triangular tissue growing from the conjunctiva onto the cornea Redness and irritation in the affected eye Blurred or decreased vision if the pterygium encroaches on the pupillary area Grittiness or a foreign body sensation Dryness or tearing in the affected eye Cosmetic concerns due to visible growth
Diagnostic & Treatment
Diagnosis Path: Diagnosis of recurrent pterygium involves a comprehensive eye examination performed by an eye care professional. The specialist will visually assess the growth, determine its extent, and distinguish it from other ocular surface lesions. Additional tests may include slit-lamp examination for detailed inspection. In some cases, imaging tests like anterior segment optical coherence tomography (AS-OCT) may be utilized to assess the thickness and depth of the lesion. The recurrent nature is confirmed through medical and surgical history, noting previous treatments and recurrences.
Treatment Protocols: Treatment options focus on controlling symptoms, preventing progression, and minimizing recurrence. Approaches may include: - **Surgical removal:** The primary treatment for significant pterygium is surgical excision. Techniques vary, but the goal is to completely remove the growth and restore normal eye surface. - **Conjunctival autografting:** During surgery, a piece of healthy conjunctiva is often transplanted to reduce recurrence risk. - **Adjunctive therapies:** Medications such as mitomycin C may be applied to inhibit fibrovascular growth and decrease the chance of recurrence. - **Postoperative care:** Includes anti-inflammatory eye drops, eye protection, and regular follow-up to monitor for recurrence. Preventive measures to reduce recurrence include wearing UV-protective sunglasses, avoiding environmental irritants, and managing ocular surface inflammation. Adoption of protective strategies is especially important in high-risk regions.
Clinical Advice & FAQs
Billing Guidance
Is H11.06 a billable ICD-10 code?
Yes, H11.06 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H11.06?
Clinical documentation must specify the nature of Recurrent pterygium of eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference